Instil Bio Inc (TIL)
26.15
+1.39
(+5.61%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
-0.24
(-0.92%)
After-Hours: 20:00
Instil Bio Cash from Investing (Quarterly): 19.81M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.81M |
| June 30, 2024 | 11.92M |
| March 31, 2024 | 9.243M |
| December 31, 2023 | 13.95M |
| September 30, 2023 | 2.319M |
| June 30, 2023 | 10.33M |
| March 31, 2023 | 14.53M |
| December 31, 2022 | 32.80M |
| September 30, 2022 | 25.37M |
| June 30, 2022 | -21.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 77.87M |
| December 31, 2021 | 59.96M |
| September 30, 2021 | -516.73M |
| June 30, 2021 | -8.493M |
| March 31, 2021 | -9.129M |
| December 31, 2020 | -45.27M |
| September 30, 2020 | -4.302M |
| June 30, 2020 | -0.275M |
| March 31, 2020 | -1.274M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-516.73M
Minimum
Sep 2021
77.87M
Maximum
Mar 2022
-17.31M
Average
9.243M
Median
Mar 2024
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -3.845B |
| Elite Pharmaceuticals Inc | 0.0176M |
| BioCardia Inc | -0.002M |
| Zevra Therapeutics Inc | -31.35M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.13M |
| Cash from Financing (Quarterly) | 0.159M |
| Free Cash Flow | -68.58M |
| Free Cash Flow Per Share (Quarterly) | -4.631 |
| Free Cash Flow Yield | -40.32% |